The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca
Leadership - AstraZeneca

Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients.
 
Temitope O Olufade
Employment - AstraZeneca
 
Karen E Skinner
Employment - Vector Oncology
 
Nicola Di Santo
No Relationships to Disclose
 
Rahul A. Shenolikar
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
 
Mark Stephen Walker
Employment - Vector Oncology
 
Lee Steven Schwartzberg
Honoraria - Amgen; Bristol-Myers Squibb; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Helsinn Therapeutics; Pfizer
Speakers' Bureau - Genentech/Roche
Research Funding - Helsinn Therapeutics